Philippa Marrack

The Scientist Date: November 25, 1996 THE SCIENTIST® The Newspaper for the Life Sciences Professional "Because of the way THE SCIENTIST is formatted, I can glean a lot from it quickly. There are a lot of interesting topics and ideas presented in brief. And that's something I appreciate because of my hectic schedule." Philippa Marrack Howard Hughes Medical Institute, National Jewish Center, Denver Throughout their scientific careers, Philippa Marrack and John Kappler, husband and wife

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The Scientist

Date: November 25, 1996

Philippa Marrack
Howard Hughes Medical Institute, National Jewish Center, Denver

"The MHC proteins are the most polymorphic proteins that exist in humans. They control graft rejection and respond to infection and autoimmunity. They have a huge effect on human health and disease," notes Marrack.

Since their discovery of the T-cell receptors 13 years ago, Marrack and Kappler have gone on to discover the reason why T cells do not react with host peptides in healthy individuals. "We discovered in 1987 that T cells don't react with peptides from their own host because they are killed off if they do," explains Marrack. But because that process is not entirely efficient, Marrack and Kappler are now working on why T cells do not always act the way they are expected to.

A reader of THE SCIENTIST, Marrack says: "Because of the way THE SCIENTIST is formatted, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies